7 in 10 Women Report Misdiagnosis in Chronic Illness

By VirentaNews Staff — May 17, 2026

It begins in the dark, long before the calendar marks it. A shift in the body so subtle it’s almost imagined—a flicker of irritability, a heaviness behind the eyes, a sudden aversion to sound. For Emma Hardy, it’s the start of a descent that repeats like clockwork, yet never feels predictable. She sits in her dimly lit flat in Leeds, clutching a mug of chamomile tea she won’t drink, staring at the unfinished draft of an article she’s tried to write for three months. The words blur. Her hands tremble. This isn’t just stress. It’s not anxiety, though it masquerades as such. It’s premenstrual dysphoric disorder (PMDD), a condition so severe it dismantles her functioning for nearly half her life. And each time she tries to explain it, she’s met with an unspoken request: make it a story with a beginning, middle, and end. But chronic illness doesn’t follow a redemptive arc. It spirals, repeats, regresses. And in that spiral, Emma found not failure—but a different kind of truth.

The Myth of the Healing Arc

Western medicine and culture alike demand that illness narratives follow a familiar script: descent, struggle, revelation, recovery. We expect patients to emerge transformed, wiser, stronger. But for the estimated 5-8% of menstruating people who live with PMDD—a severe form of premenstrual syndrome characterized by debilitating mood disturbances in the luteal phase of the menstrual cycle—this arc is not just inaccurate, it’s damaging. Symptoms include severe depression, anxiety, emotional numbness, and suicidal ideation, recurring cyclically and often dismissed as hormonal moodiness. Treatment options are limited and inconsistent, ranging from SSRIs to hormonal suppression, and even then, relief is rarely total. The notion that one can ‘overcome’ PMDD implies a finality that doesn’t exist. Instead, many, like Emma, learn to manage through a patchwork of medication, therapy, and environmental control. Yet when they speak publicly, they’re pressured to frame their experience as a triumph, obscuring the ongoing, fluctuating reality of their condition.

How Medicine Learned to Distrust Women’s Pain

This pressure to narrativize illness neatly stems from a deeper historical pattern: the medical dismissal of women’s symptoms. From the 19th-century diagnosis of ‘hysteria’ to modern misdiagnoses of fibromyalgia and endometriosis, women’s pain has long been pathologized as emotional rather than physical. PMDD entered the DSM-5 in 2013 after decades of debate, reflecting both progress and lingering skepticism. Even now, many clinicians downplay its severity or conflate it with PMS. A 2022 study published in Nature Reviews Disease Primers found that the average delay for a correct PMDD diagnosis is over two years, with many patients seeing three or more doctors before being taken seriously. This delay is not accidental—it’s systemic, rooted in a healthcare framework that struggles to validate illnesses that are cyclical, invisible, and primarily affect women. The insistence on a linear recovery narrative only reinforces this bias, implying that if a woman hasn’t ‘gotten better,’ she hasn’t tried hard enough.

The Women Rewriting the Script

Emma Hardy is part of a growing cohort of patient-advocates challenging the dominant illness narrative. Through her writing, she refuses the tidy arc, instead documenting the looping, recursive nature of living with PMDD. She’s joined by others like Dr. Sarah Winch, an Australian researcher who has called for a ‘chronic illness literacy’ that embraces complexity, and by grassroots organizations such as PMDD UK, which provides peer support and lobbies for better clinical training. These voices aren’t rejecting hope—they’re redefining it. Their motivation isn’t just personal validation but systemic change: to shift how medicine listens, how media represents chronic illness, and how society accommodates it. For many, this work is born of frustration, but also of love—for themselves, for others who’ve been silenced, for a future where saying ‘I’m not better, and that’s okay’ doesn’t feel like defeat.

What This Means for Patients and Providers

The consequences of clinging to outdated illness narratives are real. Patients internalize the belief that their suffering is a personal failure, leading to shame and delayed care. Clinicians, trained to seek resolution, may overlook the need for long-term support strategies. Employers and institutions, expecting linear recovery, fail to offer sustainable accommodations. But when we accept that chronic illness is often cyclical, we open space for more compassionate care models—ones that prioritize stability over cure, management over mastery. This shift could transform treatment for not just PMDD, but conditions like chronic fatigue syndrome, lupus, and bipolar disorder, which also follow non-linear patterns. It demands humility from medicine: the recognition that healing isn’t always progress, and that presence can be its own form of resilience.

The Bigger Picture

At stake is not just how we tell stories about illness, but how we value lives shaped by it. The hero’s journey model privileges transformation over endurance, cure over coexistence. But millions live in the in-between—not cured, not dying, but persisting. To honor that existence, we must expand our cultural imagination. Chronic illness isn’t a plot device. It’s a way of being. And in rejecting the false promise of closure, people like Emma aren’t giving up—they’re claiming a truer kind of strength.

What comes next isn’t recovery, at least not in the way we’ve been taught to imagine it. It’s acceptance of recurrence. It’s building lives around rhythms, not resolutions. It’s finding community in the spiral. And perhaps, in that messiness, there’s a kind of liberation: the freedom to say, ‘This is not the end. It’s not even a chapter. It’s just today.’ And today, for now, is enough.

Source: The Guardian